Nektar Therapeutics
NKTR
#4531
Rank
NZ$3.87 B
Marketcap
NZ$134.98
Share price
1.69%
Change (1 day)
917.65%
Change (1 year)

Nektar Therapeutics (NKTR) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$0.15 Billion

According to Nektar Therapeutics 's latest financial reports the company's total debt is NZ$0.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Nektar Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.14 B-18.58%
2024-12-31NZ$0.18 B-2.35%
2023-12-31NZ$0.18 B-10.08%
2022-12-31NZ$0.20 B-1.19%
2021-12-31NZ$0.20 B0.64%
2020-12-31NZ$0.20 B-65.63%
2019-12-31NZ$0.60 B64.61%
2018-12-31NZ$0.36 B6.63%
2017-12-31NZ$0.34 B-1.77%
2016-12-31NZ$0.35 B-2.82%
2015-12-31NZ$0.36 B112.02%
2014-12-31NZ$0.17 B2.63%
2013-12-31NZ$0.16 B0.09%
2012-12-31NZ$0.16 B-43.54%
2011-12-31NZ$0.29 B-2.19%
2010-12-31NZ$0.30 B-6.57%
2009-12-31NZ$0.32 B-20.63%
2008-12-31NZ$0.40 B-7.74%
2007-12-31NZ$0.43 B-29.33%
2006-12-31NZ$0.62 B-3.04%
2005-12-31NZ$0.64 B129.92%
2004-12-31NZ$0.27 B-53.89%
2003-12-31NZ$0.60 B-4.63%
2002-12-31NZ$0.63 B-20.62%
2001-12-31NZ$0.79 B10.58%
2000-12-31NZ$0.72 B233.1%
1999-12-31NZ$0.21 B2185.07%
1998-12-31NZ$9.49 M6.27%
1997-12-31NZ$8.93 M1478.15%
1996-12-31NZ$0.56 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$84.03 B 55,797.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$112.13 B 74,489.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$95.73 B 63,577.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$17.14 B 11,305.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$86.50 B 57,437.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$51.10 B 33,892.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$3.05 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.12 B-18.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland